Accessibility settings

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/88665, first published .
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study

Lisa Pilgram   1, 2, 3 , MD ;   Kai Yang   1, 2 , PhD ;   Ana-Alicia Beltran-Bless   4 , MD ;   Gregory R Pond   5 , PhD ;   Lisa Vandermeer   6 , MSc ;   John Hilton   7 , MD ;   Marie-France Savard   4 , MD ;   Andreanne LeBlanc   8 , MD ;   Lois Shepherd   9 , MD ;   Bingshu Chen   9 , PhD ;   John MS Bartlett   10 , PhD ;   Karen J Taylor   10 , PhD ;   Jane Bayani   11, 12 , PhD ;   Sarah Barker   11 , PhD ;   Melanie Spears   11, 12 , PhD ;   Cornelis JH van der Velde   13 , MD ;   Elma Meershoek-Klein Kranenbarg   13 , MSc ;   Luc Dirix   14 , MD, PhD ;   Elizabeth Mallon   15 , MBChB ;   Annette Hasenburg   16 , MD ;   Christos Markopoulos   17 , MD, PhD ;   Lamin Juwara   1, 2 , PhD ;   Fida K Dankar   2 , PhD ;   Mark Clemons   7 , MD ;   Khaled El Emam   1, 2 , PhD

1 School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

2 Research Institute, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada

3 Department of Nephrology and Medical Intensive Care, Charité - Universitaetsmedizin Berlin, Berlin, Germany

4 Division of Medical Oncology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

5 Department of Oncology, McMaster University, Hamilton, ON, Canada

6 Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada

7 Ottawa Hospital Cancer Center, Ottawa Hospital Research Institute, Ottawa, ON, Canada

8 Division of Medical Oncology and Hematology, CHUM, Université de Montréal, Montreal, QC, Canada

9 Canadian Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

10 Edinburgh Cancer Research, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, Scotland, United Kingdom

11 Diagnostic Development, Ontario Institute for Cancer Research, Toronto, ON, Canada

12 Department of Laboratory Medicine and Pathobiology, University of Toronto, Ontario, ON, Canada

13 Department of Surgery, Leiden University Medical Center, Leiden, South Holland, The Netherlands

14 St. Augustinus Hospital, Antwerp, Belgium

15 Department of Pathology, NHS Greater Glasgow and Clyde, Glasgow, Scotland, United Kingdom

16 Department of Gynecology and Obstetrics, University Center Mainz, Mainz, Germany

17 Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece

Corresponding Author: